GeneS welcome serious and interested investors to back our mission to create a "Right Drug, RightDose, First Time" world that will transform personalised medicine. GeneS qualifies for the Early-Stage InnovationCompany (ESIC) incentive.
Through ESIC, investors are eligible for:
If you are interested in investing in GeneS, please contact us at support@gene-s.com